SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-033294
Filing Date
2021-02-09
Accepted
2021-02-09 07:10:01
Documents
15
Period of Report
2021-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100234d8k.htm   iXBRL 8-K 31552
2 EX-10.1 d100234dex101.htm EX-10.1 343224
3 EX-99.1 d100234dex991.htm EX-99.1 12482
4 EX-99.2 d100234dex992.htm EX-99.2 41858
  Complete submission text file 0001193125-21-033294.txt   627674

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ortx-20210204.xsd EX-101.SCH 3074
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20210204_lab.xml EX-101.LAB 17304
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20210204_pre.xml EX-101.PRE 10931
8 EXTRACTED XBRL INSTANCE DOCUMENT d100234d8k_htm.xml XML 3342
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 21603921
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences